PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63 | -1.6% | 10,306 | +1.3% | 0.00% | – |
| Q2 2023 | $64 | +30.6% | 10,169 | -0.5% | 0.00% | – |
| Q1 2023 | $49 | -79.1% | 10,218 | -62.0% | 0.00% | – |
| Q4 2022 | $234 | -99.9% | 26,918 | -0.1% | 0.00% | – |
| Q3 2022 | $320,000 | -16.2% | 26,932 | +0.6% | 0.00% | – |
| Q2 2022 | $382,000 | -3.0% | 26,781 | +41.5% | 0.00% | – |
| Q1 2022 | $394,000 | -9.8% | 18,933 | +0.1% | 0.00% | – |
| Q4 2021 | $437,000 | -22.7% | 18,908 | -0.3% | 0.00% | -100.0% |
| Q3 2021 | $565,000 | -26.9% | 18,973 | -16.1% | 0.00% | 0.0% |
| Q2 2021 | $773,000 | +84.9% | 22,617 | +78.1% | 0.00% | – |
| Q1 2021 | $418,000 | -35.9% | 12,700 | +19.8% | 0.00% | -100.0% |
| Q4 2020 | $652,000 | – | 10,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
| INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
| Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
| Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
| COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
| Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
| Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
| Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
| RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
| HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |